XNAS · PHARMACEUTICAL PREPARATIONS · PHARMACEUTICAL PREPARATIONS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Regeneron posted Q1 2026 revenue of $3.6 billion, up 19% from $3.03 billion a year ago, driven by explosive growth across its drug portfolio.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -1 | $712 | $712 |
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -2 | $711 | $1,422 |
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -6 | $709 | $4,257 |
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -4 | $707 | $2,830 |
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -7 | $707 | $4,947 |
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -14 | $706 | $9,878 |
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -24 | $703 | $16,883 |
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -15 | $702 | $10,537 |
| 5/1/2026 | RYAN ARTHUR F | — | SELL | -5 | $702 | $3,509 |
| 4/1/2026 | RYAN ARTHUR F | — | SELL | -1 | $771 | $771 |
| 4/1/2026 | RYAN ARTHUR F | — | SELL | -3 | $773 | $2,318 |
| 4/1/2026 | RYAN ARTHUR F | — | SELL | -8 | $774 | $6,189 |
| 4/1/2026 | RYAN ARTHUR F | — | SELL | -14 | $776 | $10,858 |
| 4/1/2026 | RYAN ARTHUR F | — | SELL | -13 | $777 | $10,096 |
| 4/1/2026 | RYAN ARTHUR F | — | SELL | -9 | $777 | $6,997 |
| 4/1/2026 | RYAN ARTHUR F | — | SELL | -4 | $778 | $3,113 |
| 4/1/2026 | RYAN ARTHUR F | — | SELL | -40 | $780 | $31,188 |
| 3/2/2026 | RYAN ARTHUR F | — | SELL | -7 | $777 | $5,442 |
| 3/2/2026 | RYAN ARTHUR F | — | SELL | -2 | $778 | $1,557 |
| 3/2/2026 | RYAN ARTHUR F | — | SELL | -5 | $780 | $3,898 |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 8,446,366 | $8,877,384,199 | — | 8/13/2024 |
| Vanguard Group | 9,075,153 | $7,004,838,346 | — | 1/29/2026 |
| State Street | 4,660,808 | $3,597,537,871 | — | 2/13/2026 |
| JP Morgan Chase | 4,002,160 | $3,089,148,831 | — | 2/11/2026 |
| Fidelity (FMR) | 2,319,566 | $1,790,403,167 | — | 2/17/2026 |
| AQR Capital | 995,710 | $768,518,494 | — | 2/17/2026 |
| Citadel Advisors | 684,270 | $528,167,485 | — | 2/17/2026 |
| Millennium Management | 443,768 | $342,531,206 | — | 2/17/2026 |
| Two Sigma | 281,151 | $217,012,022 | — | 2/17/2026 |
| Point72 | 265,827 | $205,183,886 | — | 2/17/2026 |
| DE Shaw | 178,475 | $137,759,498 | — | 2/17/2026 |
| Bridgewater Associates | 72,745 | $56,149,683 | — | 2/13/2026 |